TranS1 Inc. Opens New Training Facility in Raleigh, NC

        Print
| Source: Baxano Surgical, Inc.

WILMINGTON, N.C., Feb. 24, 2012 (GLOBE NEWSWIRE) -- TranS1 Inc. (Nasdaq:TSON), a medical device company focused on designing, developing and marketing minimally invasive spine products to treat degenerative conditions of the spine affecting the lower lumbar region, announced today the opening of its new training center in Raleigh, NC. In conjunction with the opening, the Company hosted its first visiting surgeon program at the new facility. The centerpiece of the Raleigh site is a state-of-the art operating room unit including a fully equipped surgical suite. The facility provides cadaveric capabilities to allow hands-on training for spine surgeons.

"Effective training is a key building block of our business. This new facility provides a convenient location for our surgeons to gain hands-on experience with the instrumentation and anatomy involved with performing a pre-sacral AxiaLIF® implant or a VEOTM Direct Lateral System procedure. This will ultimately drive strong outcomes," stated Ken Reali, TranS1's President and CEO.

The first surgeon to visit the Raleigh TranS1 office was Frederik A. Pennings, MD, Director of Minimally Invasive Spine Surgery, Department of Neurosurgery, UMass Memorial Medical Center. "Comprehensive surgeon training is essential to the safe and effective adoption of any surgical technology.   TranS1's superb lab replicates real world application of the Company's advanced minimally invasive technologies."

About TranS1 Inc.

TranS1 is a medical device company focused on designing, developing and marketing products to treat degenerative conditions of the spine affecting the lower lumbar region. TranS1 currently markets the AxiaLIF family of products for single and two level lumbar fusion, the VEO lateral access and interbody fusion system, and the VectreTM and AvatarTM posterior fixation systems for lumbar fixation supplemental to AxiaLIF fusion. TranS1 was founded in May 2000 and is headquartered in Wilmington, North Carolina. For more information, visit www.trans1.com.

Investors:
TranS1 Inc.
Joseph P. Slattery, 910-332-1700
Executive Vice-President and Chief Financial Officer

Westwicke Partners
Mark Klausner, 443-213-0501